Drug intelligence / Profile preview

dextranomer

Development stage
Phase 3
Lead developer
Pfizer
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Topical, Submucosal
01

Overview

Dextranomer is a synthetic, cross-linked hydrophilic dextran polymer used primarily as a wound-cleansing agent and a biocompatible bulking agent. When applied topically to exudative wounds, such as venous stasis or decubitus ulcers, it acts via capillary action to absorb exudate, debris, and microorganisms into its bead structure, facilitating natural healing. In its injectable form (often combined with sodium hyaluronate), it serves as a submucosal bulking agent in the anal canal to treat fecal incontinence by improving bowel control. Historically developed by Pharmacia, it is now marketed under various brands including Solesta and Deflux for internal use and Debrisan for topical wound care.

Brand names
DebrisanExudexSolestaDeflux
Other names
dextranomercross-linked dextran polymer

Beyond the preview

Go deeper on dextranomer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dextranomer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call